Ketamine vs Prozac: Which Works Faster for Depression?

You've been on the antidepressant carousel. You've waited the six-to-eight weeks, adjusted the dose, waited again, and maybe switched to something new only to repeat the whole cycle. Now you're weighing whether to try yet another SSRI or explore something different entirely. You're not alone in that frustration. Roughly one in three people with depression don't respond adequately to standard antidepressants, and that number climbs with each medication that doesn't work.

The short answer: Ketamine works much faster than Prozac. It can reduce depression symptoms within hours, while Prozac typically takes four to six weeks for full effect. The two often fill different roles in depression treatment rather than substituting for each other.

What Is Prozac?

Prozac (fluoxetine) is an SSRI antidepressant approved by the FDA in 1987 for major depressive disorder, obsessive-compulsive disorder (OCD), bulimia, and panic disorder, and in combination with olanzapine for bipolar I depression. It remains one of the most widely prescribed antidepressants in the US.

Fluoxetine works through serotonin, a brain chemical involved in mood regulation. Because it mainly targets serotonin, it's generally well-tolerated compared to older antidepressant classes like tricyclics and MAOIs. That tolerability, combined with decades of real-world safety data, is why SSRIs like Prozac are still the starting point for most people with depression.

One downside is how long it takes to know whether Prozac will work. If response hasn't begun within four to six weeks of treatment, studies suggest a 73–88% chance you won't respond by week eight. That's a failed trial, not partial improvement to build on.

What Is Ketamine Therapy?

Ketamine was originally developed as a surgical anesthetic in the 1960s, synthesized in 1962 and first given to humans in 1964. Its potential for treating depression emerged around 2000, when researchers at Yale gave a single low dose to people with depression and saw rapid improvement. The FDA later approved esketamine (Spravato), a nasal spray form of ketamine, for treatment-resistant depression (TRD) on March 5, 2019.

Ketamine therapy is primarily aimed at people who haven't improved after trying two antidepressants at adequate doses. It comes in several forms: IV infusions at clinics, the FDA-approved Spravato nasal spray (self-administered at certified healthcare facilities under supervision), and sublingual tablets used in at-home telehealth program

. Spravato is the only form with specific FDA approval for depression; IV and sublingual ketamine for depression are used off-label, which is common practice in psychiatry.

How Ketamine and Prozac Work Differently

Prozac works through serotonin in a slow, gradual process that requires daily dosing to accumulate its effect. Ketamine works through the NMDA and glutamate system, a pathway that behaves very differently from SSRIs.

At the neural level, ketamine creates rapid changes in the brain systems involved in mood and cognitive flexibility. It supports new synaptic connections in areas affected by depression, and the process starts within hours rather than weeks.

Duration also differs. Prozac requires continuous daily dosing to maintain benefit. A single ketamine dose can produce relief lasting roughly one week, which is why treatment involves a series of sessions rather than a single administration.

The Speed Comparison

Speed matters most when you're in acute distress.

In the NIMH trial that put ketamine on the map, 71% of people with treatment-resistant depression responded within 24 hours. Effects were detectable as early as 40 minutes by self-report. Later randomized controlled trials using midazolam as an active placebo replicated the rapid effect, with roughly 64% of recipients meeting response criteria at 24 hours versus 28% in the comparison group.

For people experiencing suicidal thoughts, the timeline matters even more. Research shows ketamine can reduce suicidal ideation within 40 minutes.

Prozac's timeline looks very different. Among people who eventually respond to fluoxetine, about 55% show onset of response by week two, and roughly 80% by week four. Full benefit continues building over at least six weeks.

How Well Each One Works

This comparison is useful, but it isn't perfectly apples-to-apples. Most Prozac data comes from people with general depression, while most ketamine data comes from people whose depression has already resisted multiple treatments.

A large synthesis of double-blind placebo-controlled fluoxetine trials found that about 55% of adults responded at six weeks versus roughly 34% on placebo, with remission rates of about 46% versus 30%.

Ketamine, tested in a harder-to-treat population, shows strong short-term results. The NIMH trial found a 71% response rate and 29% remission rate within 24 hours among people with treatment-resistant depression. A meta-analysis of 24 trials with 1,877 participants found people receiving IV ketamine were about three times more likely to respond than those in the comparison group.

One notable subgroup: an NIMH analysis found that people with anxious depression responded especially well to ketamine, with median time to relapse of 19 days compared to just 1 day in non-anxious responders. Anxious depression typically responds worse to traditional antidepressants, which makes ketamine particularly worth considering if that describes you.

What Improvement Can Actually Feel Like

Clinical trials measure symptom reduction on standardized scales. But what does that feel like in daily life?

With ketamine, the shift can be sudden. People often describe it as the weight lifting, or the volume turning down on the constant background noise of dread. Within hours of a session, the intensity of depression or suicidal thinking can quiet enough that you notice the change before the day is out. You might wake up the next morning and find you can think about the day ahead without the usual negotiation.

With Prozac, the change is slower and less dramatic. You often don't realize it's working until you look back three weeks in and notice you've been getting out of bed more easily, or that a friend mentioned you seemed lighter. The shift is more like the gradual return of okay than a sudden lift.

That experience is also why ketamine treatment usually pairs with therapy. Integration work turns the shift into lasting change rather than a temporary mood lift.

Side Effects and Safety

Prozac's most common side effects include nausea, insomnia, headache, and nervousness. The side effect that most often drives people away from SSRIs is sexual dysfunction. The Prozac label includes a specific warning that symptoms of sexual dysfunction occasionally persist after discontinuation of fluoxetine.

In 2021, the FDA expanded SSRI and SNRI labeling to require warnings about sexual side effects during treatment across the class. Prozac also carries the standard antidepressant black box warning about increased suicidal thoughts in people under 25 during early treatment.

Ketamine's side effects are more intense but shorter-lived. Dissociation, dizziness, nausea, and temporary blood pressure spikes are common during treatment sessions. These effects are dose-related and typically resolve within a few hours.

Spravato specifically carries a boxed warning for sedation, dissociation, and abuse potential, which is why its protocol requires monitoring for at least two hours after each session at a certified clinic. A systematic review of clinical trials found no dependence or addiction during supervised treatment periods. Innerwell maintains a detailed guide on ketamine safety for anyone who wants to dig into the evidence.

Prozac has more than three decades of post-marketing safety data. Esketamine was approved in 2019, and a recent review flagged long-term risks as a remaining question.

Cost and Access

For a lot of people, this is where the decision gets very real. Even a promising treatment may not be practical if you can't access it.

The cost gap between these treatments is significant. Generic fluoxetine runs roughly $3–$20 per month and is covered by virtually every insurance plan as a first-tier generic.

Ketamine therapy costs more, but the range varies widely by format. IV infusions at clinics typically run $400–$800 per session and are often out-of-pocket.

Spravato has a growing coverage pathway through Medicare Part B and some Medicaid programs, which makes it more financially accessible than clinic-based IV infusions for people who qualify. At-home sublingual programs fall between these options, with pricing that can drop to $54–$75 per session through insurance partnerships.

Can You Take Ketamine and Prozac Together?

Yes, and for most people it's the clinical standard rather than a workaround. An expert consensus paper in the American Journal of Psychiatry found no significant interactions between ketamine and SSRIs (including fluoxetine), and the FDA-approved Spravato label specifies use alongside an oral antidepressant for its primary TRD indication. Continuing your SSRI through ketamine treatment may extend the antidepressant effect.

Automated drug databases may show you something different, sometimes flagging a "major interaction" between the two. This reflects two pharmacological realities worth understanding rather than a reason to avoid the combination:

• Central nervous system overlap. Both medications act on the same system, so theoretically the combination could amplify side effects like dizziness or sedation during a session.
• Metabolic interaction. Fluoxetine inhibits the liver enzyme CYP3A4, which partially metabolizes ketamine. This may slightly elevate ketamine levels during treatment.

Supervised programs account for these through clinical monitoring, appropriate dosing, and a full medication review before treatment. Medications that do require more caution are high-dose benzodiazepines (which can blunt ketamine's antidepressant effect), MAOIs, and naltrexone.

Which Treatment Makes Sense for Your Situation

SSRIs like Prozac remain the right starting point for most people experiencing depression for the first time. They're affordable, well-studied, and effective for a majority of people. If you haven't yet tried two adequate antidepressant courses, starting there makes clinical sense. If Prozac doesn't work or causes intolerable side effects, ask your prescriber about Prozac alternatives.

Ketamine therapy may make sense if you've already tried multiple antidepressants without meaningful improvement, if you're dealing with acute suicidal thoughts that need faster relief than SSRIs can provide, or if anxious or atypical depression has made standard antidepressants less effective for you.

The medication can open a door; what you do during that period shapes how much lasting benefit you get.

How Innerwell's At-Home Ketamine Therapy Works

If you've been through the SSRI cycle and are considering ketamine, the next question is finding the right program. Innerwell combines at-home sublingual ketamine therapy with Master's and Doctoral level licensed mental health professionals who guide you through the entire process, from preparation through integration. This isn't ketamine dropped off with minimal supervision. It's structured mental health care with clinical oversight at every step.

The process:

1. Evaluation: A full psychiatric assessment reviews your treatment history and current medications to determine whether ketamine therapy is appropriate for your situation.
2. Delivery: A licensed pharmacy ships sublingual ketamine tablets to your home. You take each dose during a guided session from a comfortable, familiar setting. No clinic visits are required.
3. Preparation and integration: Therapy sessions before and after each ketamine experience focus on setting intentions, processing what comes up, and building new patterns while your brain is most receptive to change.
4. Ongoing monitoring: Your clinical team tracks your progress and adjusts the treatment plan as needed throughout the program.

With insurance partnerships, sessions run $54–$75 each. Self-pay options range from $83–$125 per session.

Cost

Clinical Outcomes

Innerwell's clinical data shows a 69% reduction in depression symptoms and a 60% reduction in anxiety symptoms after 10 weeks. Within four weeks, 87% of people see improvement, and the program holds a 4.7 out of 5 average rating.

Take the free assessment to see if ketamine therapy might be right for you.

Frequently Asked Questions

Is Prozac worth trying before ketamine?

If you haven't tried at least two antidepressants at adequate doses, yes. SSRIs are affordable, well-studied, and effective for many people. The clinical definition of treatment-resistant depression requires that you've given at least two medications a fair trial, each for a minimum of six weeks at the right dose. Ketamine therapy is most appropriate after you've passed that bar.

Can I switch from Prozac to ketamine?

You typically don't need to. Most protocols continue Prozac through ketamine treatment, since the two work on different pathways and combine safely under supervision. If stopping does become part of your plan, a gradual taper managed by your prescriber is usually required because of Prozac's long half-life. Innerwell's clinical team coordinates with your existing providers to determine what makes sense.

How long do ketamine's effects last?

A single dose provides relief for roughly one week in early research. With repeated dosing and therapeutic support, responses can extend considerably; the Spravato SUSTAIN-3 long-term extension study, for example, followed patients for several years and found that most responders maintained improvement. Programs that include multiple sessions and integration therapy tend to produce more durable results than standalone infusions, because the therapeutic work during the period of increased openness reinforces lasting changes.